Healthcare provider profile · identity verified

Lauri F Lopp, MD

Family Practice · SPRINGFIELD, IL · NPI 1831189539

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	154	30
Gabapentin	Gabapentin	126	22
Levothyroxine Sodium	Levothyroxine Sodium	106	15
Atorvastatin Calcium	Atorvastatin Calcium	100	33
Lisinopril	Lisinopril	95	22
Famotidine	Famotidine	94	14
Metformin Hcl	Metformin Hcl	80	18
Pravastatin Sodium	Pravastatin Sodium	79	15
Pregabalin	Pregabalin	70	15
Metoprolol Succinate	Metoprolol Succinate	66	18
Amlodipine Besylate	Amlodipine Besylate	64	23
Albuterol Sulfate Hfa	Albuterol Sulfate	62	16
Furosemide	Furosemide	60	suppressed
Glipizide	Glipizide	60	suppressed
Duloxetine Hcl	Duloxetine Hcl	59	11
Omeprazole	Omeprazole	59	19
Hydrochlorothiazide	Hydrochlorothiazide	58	13
Fluoxetine Hcl	Fluoxetine Hcl	57	suppressed
Tramadol Hcl	Tramadol Hcl	54	11
Pantoprazole Sodium	Pantoprazole Sodium	52	15
Simvastatin	Simvastatin	52	12
Escitalopram Oxalate	Escitalopram Oxalate	51	suppressed
Trulicity	Dulaglutide	51	suppressed
Losartan Potassium	Losartan Potassium	49	16
Metoprolol Tartrate	Metoprolol Tartrate	46	13
Potassium Chloride	Potassium Chloride	45	suppressed
Montelukast Sodium	Montelukast Sodium	43	suppressed
Mirtazapine	Mirtazapine	39	suppressed
Sertraline Hcl	Sertraline Hcl	36	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	32	suppressed
Trazodone Hcl	Trazodone Hcl	31	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Baclofen	Baclofen	26	suppressed
Carvedilol	Carvedilol	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Ozempic	Semaglutide	25	suppressed
Clonazepam	Clonazepam	24	suppressed
Incruse Ellipta	Umeclidinium Bromide	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Prednisone	Prednisone	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Risperidone	Risperidone	16	suppressed
Leflunomide	Leflunomide	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Eliquis	Apixaban	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Nystatin	Nystatin	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Naproxen	Naproxen	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Nystop	Nystatin	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Atenolol	Atenolol	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Lactulose	Lactulose	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error